Biomarker-based Dosing

Home
Register

JOIN THE JOURNEY

Saluda Medical

Pioneers of biomarker-based Dosing in Neuromodulation

With over 10 years of groundbreaking research, Saluda Medical has unlocked the power of ONE TRILLION+ ECAPs, changing the world of neuromodulation. We're empowering clinicians with an objective and physiologic measure of neural activation, harnessing the power of accuracy and innovation to reshape the future of pain relief.

Learn more about Generation 4 and join us on:

20. - 21. February 2025

Location: am Kölner Dom

Event management software powered by Swoogo